Company intelligence / Profile preview

MCAPITAL

Ownership: Private
Development stage: Other

Overview

MCAPITAL appears to be an active U.S. financial advisory firm focused on the healthcare ecosystem rather than a drug-development biotech or pharmaceutical operating company. Publicly available descriptions characterize it as a healthcare-dedicated advisory business, with investment and transaction activity tied to healthcare companies. There is no clear evidence that MCAPITAL itself develops therapeutic products, runs a clinical pipeline, or owns drug candidates. As a result, it is better classified as a healthcare-focused finance/advisory company than as a biotech, pharma, CRO, or therapeutic platform company.

Industry: Investors

Beyond the preview

Go deeper on MCAPITAL.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MCAPITAL.

Explore the full profile